StephaniePMathewsMD
Pathology • Chapel Hill, NCHematopathology, Anatomic Pathology, Clinical Pathology
Physician
Dr. Mathews is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-1072Fax+1 919-843-6949- Is this information wrong?
Education & Training
University of North Carolina HospitalsFellowship, Hematopathology, 2009 - 2010- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 2005 - 2009
University of South Carolina School of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2005 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 21 citationsEarly Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bha...> ;Blood Advances. 2021 Sep 13
- 11 citationsMulti-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta...> ;American Journal of Hematology. 2021 Jul 29
- 3 citationsIntensive Induction Regimens after Deferring Initial Therapy for Mantle Cell Lymphoma Are Not Associated with Improved SurvivalKrithika Shanmugasundaram, Subir Goyal, J. Switchenko, Oscar Calzada, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J...> ;European Journal of Haematology. 2021 May 11
- Join now to see all
Abstracts/Posters
- Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous TransplantStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell LymphomaStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell LymphomaStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
